Insider Selling News: Gilead Sciences, Inc. (GILD), Twitter Inc (TWTR), Intercept Pharmaceuticals Inc (ICPT), Novavax, Inc. (NVAX)


Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Twitter Inc (NYSE:TWTR), and Novavax, Inc. (NASDAQ:NVAX).

Gilead Sciences, Inc.

President and COO John F. Milligan disposed 100,000 Gilead Sciences shares (8.86% of total stake), valued at $11,404,678, in two transactions dated June 8. Milligan now holds 1,029,108 of the company’s shares that are valued at $122,597,636.

Click Here to see the performance of Gilead insiders.

 

Twitter Inc

Director Evan Clark Williams sold 372,000 Twitter shares valued at $13,356,541, in multiple transactions dated June 9 to 10. The shares were sold via automatic sale program. Williams now holds 2,829,196 of the company’s shares.

Click Here to see the performance of Twitter insiders.

Intercept Pharmaceuticals Inc

CSO Luciano Adorini unloaded 4,000 Intercept Pharmaceuticals shares, valued at $993,580, in two transactions dated June 8. The shares were sold via automatic sale program. Adorini now holds 10,060 of the company’s shares that are valued at $2,493,170.

Click Here to see the performance of Intercept Pharmaceuticals insiders.

Novavax, Inc.

Director Rajiv Modi dumped 551,081 Novavax shares (15.77% of total stake), valued at $4,944,943, in three transactions dated June 8 to 10. Modi now holds 2,944,238 of the company’s shares that are valued at $26,468,700.

Click Here to see the performance of Novavax insiders.